Natera Inc (NTRA)
Natera - Natera Announces Strong Preliminary Fourth Quarter and 2025 Financial Results Driven by Record Signatera™ Growth
Natera Inc (NTRA)
Natera Announces Strong Preliminary Fourth Quarter and 2025 Financial Results Driven by Record Signatera™ Growth
TEVA (TEVA)
Teva Pharmaceutical Industries Ltd. - Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference: Pivot to Growth Strategy Delivering Growth and Transforming through Innovation
Teva Pharmaceutical Industries Limited (TEVA)
Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference: Pivot to Growth Strategy Delivering Growth and Transforming through Innovation
Mesoblast Limited (MESO)
Appendix 3Y for Lyn Cobley
TEVA (TEVA)
Teva Pharmaceutical Industries Ltd. - Royalty Pharma and Teva Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo
Royalty Pharma (RPRX)
Royalty Pharma and Teva Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo
Teva Pharmaceutical Industries Limited (TEVA)
Royalty Pharma and Teva Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo
TEVA (TEVA)
Teva Pharmaceutical Industries Ltd. - Teva and Royalty Pharma Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo
Guardant Health Inc (GH)
Guardant Health, Inc. - Guardant Health Announces Preliminary Fourth Quarter and Full Year 2025 Results